Bio-Techne (TECH) EBIT (2016 - 2025)
Historic EBIT for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $54.5 million.
- Bio-Techne's EBIT rose 1485.06% to $54.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $117.0 million, marking a year-over-year decrease of 4158.28%. This contributed to the annual value of $102.3 million for FY2025, which is 5052.64% down from last year.
- Bio-Techne's EBIT amounted to $54.5 million in Q4 2025, which was up 1485.06% from $47.7 million recorded in Q3 2025.
- Over the past 5 years, Bio-Techne's EBIT peaked at $94.5 million during Q2 2023, and registered a low of -$23.9 million during Q2 2025.
- In the last 5 years, Bio-Techne's EBIT had a median value of $59.3 million in 2021 and averaged $57.2 million.
- As far as peak fluctuations go, Bio-Techne's EBIT skyrocketed by 7446.45% in 2021, and later tumbled by 15206.99% in 2025.
- Quarter analysis of 5 years shows Bio-Techne's EBIT stood at $62.3 million in 2021, then rose by 8.89% to $67.9 million in 2022, then tumbled by 44.02% to $38.0 million in 2023, then increased by 24.77% to $47.4 million in 2024, then grew by 14.85% to $54.5 million in 2025.
- Its last three reported values are $54.5 million in Q4 2025, $47.7 million for Q3 2025, and -$23.9 million during Q2 2025.